Text Size

Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies

Nguyen Q.D., Merrill P.T., Sepah Y.J., Ibrahim M.A., Banker A., Leonardi A., Chernock M., Mudumba S., Do D.V.


  • 2018
  • Ophthalmology
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Categories

    Preclinical development

  • Affiliations

    Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, United States; Department of Ophthalmology, Rush University Medical Center, Chicago, IL, United States; Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, United States; Banker's Retina Clinic and Laser Center, Navrangpura, Ahmedabad, India; Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy; Santen, Inc., Emeryville, CA, United States; Ocular Imaging Research and Reading Center (OIRRC), Menlo Park, CA, United States

Related Publications

Rapid and efficient generation of mature retinal organoids derived from human pluripotent stem cells via optimized pharmacological modulation of Sonic hedgehog, activin A, and retinoic acid signal transduction

Matsushita T.; Onishi A.; Matsuyama T.; Masuda T.; Ogino Y.; Kageyama M.; Takahashi M.; Uchiumi F.


Rotenone-Induced Optic Nerve Damage and Retinal Ganglion Cell Loss in Rats

Yamamoto Y.; Taniguchi T.; Shimazaki A.


Aging-associated changes of optical coherence tomography-measured ganglion cell-related retinal layer thickness and visual sensitivity in normal Japanese

Iwase A., Higashide T., Fujii M., Ohno Y., Tanaka Y., Kikawa T., Araie M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022